Interleukin-6 is elevated in synovial fluid of patients with focal cartilage defects and stimulates cartilage matrix production in an in vitro regeneration model
about
Osteoarthritic cartilage explants affect extracellular matrix production and composition in cocultured bone marrow-derived mesenchymal stem cells and articular chondrocytes.Cytokine profiles in the joint depend on pathology, but are different between synovial fluid, cartilage tissue and cultured chondrocytes.Subchondral bone influences chondrogenic differentiation and collagen production of human bone marrow-derived mesenchymal stem cells and articular chondrocytes.Expression of phosphocitrate-targeted genes in osteoarthritis menisci.Posttraumatic knee osteoarthritis following anterior cruciate ligament injury: Potential biochemical mediators of degenerative alteration and specific biochemical markers.Effects of phosphorylatable short peptide-conjugated chitosan-mediated IL-1Ra and igf-1 gene transfer on articular cartilage defects in rabbits.Obesity-associated metabolic syndrome spontaneously induces infiltration of pro-inflammatory macrophage in synovium and promotes osteoarthritis.Investigations of wear particles and selected cytokines in human osteoarthritic knee joints.Expression of synovial fluid biomarkers in patients with knee osteoarthritis and meniscus injury.Pronounced biomaterial dependency in cartilage regeneration using nonexpanded compared with expanded chondrocytes.Harpagoside suppresses IL-6 expression in primary human osteoarthritis chondrocytes.Synovial fluid proteomics in the pursuit of arthritis mediators: An evolving field of novel biomarker discovery.Modulation of Gene Expression in Infrapatellar Fat Pad-Derived Mesenchymal Stem Cells in Osteoarthritis.Contribution of the Interleukin-6/STAT-3 Signaling Pathway to Chondrogenic Differentiation of Human Mesenchymal Stem Cells.Interleukin-6 from subchondral bone mesenchymal stem cells contributes to the pathological phenotypes of experimental osteoarthritis.
P2860
Q33900522-4263CB62-A1AF-416D-9280-20C1EED38EC2Q34362994-BC760160-8425-45BA-A966-1ACC8E360358Q34402219-CDAD27C4-4DC3-4487-9319-B0766B0BD310Q34694718-6D0B75F5-F32E-4E26-AE13-41F23684FA51Q35180074-7471DC16-549A-4413-AFFE-31D4D9E10309Q35414105-C0864C31-AD64-4EF6-95A4-79BA718FD17FQ38634928-6AE62F61-4D1E-4B7B-8983-FB5DAF7336C5Q39574950-201F27A1-8603-46C7-9EB7-E6DB46D5980DQ41116359-D979F43F-5AEF-4DF0-A6C4-BF96F0365424Q43586499-EC685448-7AB8-4FC5-8D6C-89839E65D492Q46563144-067F1B2C-4764-4CAD-9E32-808650934ED4Q47333777-D5EECC68-5739-4519-B75A-D138B55AC3BFQ50204426-34949216-0645-4D70-AB72-B4AACCD32C37Q53633328-B3EFAC7D-42BD-4871-B6A0-3FCCD1E9776DQ55241596-CBF7D9AE-76AC-45D3-A56B-189684BB96A3
P2860
Interleukin-6 is elevated in synovial fluid of patients with focal cartilage defects and stimulates cartilage matrix production in an in vitro regeneration model
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Interleukin-6 is elevated in s ...... an in vitro regeneration model
@en
type
label
Interleukin-6 is elevated in s ...... an in vitro regeneration model
@en
prefLabel
Interleukin-6 is elevated in s ...... an in vitro regeneration model
@en
P2093
P2860
P356
P1476
Interleukin-6 is elevated in s ...... an in vitro regeneration model
@en
P2093
Anika I Tsuchida
Arjan G J Bot
Bernd Geurts
Daniel B F Saris
Gerjo J V M van Osch
Joris E J Bekkers
Marijn Rutgers
Michiel Beekhuizen
Wouter J A Dhert
P2860
P2888
P356
10.1186/AR4107
P577
2012-12-03T00:00:00Z
P5875
P6179
1034855447